Recently, I discussed a couple of reports that have come to light, potentially exposing the shortcomings of an FDA policy on “fast tracking” the approval of certain new drugs. Now, the FDA is in the middle of a large operation to remedy other policy issues…
Every time you turn on the television, you are most likely bombarded by a barrage of advertisements for prescription drugs. While you might be wary of marketer’s claims and promises as to their effect, you can at least rest assured that all have passed stringent…
In 2014, A young woman in Snellville, Georgia visited her doctor with claims of depression. Her physician prescribed lamotrigine, also marketed under the tradename Lamictal, a mood-stabilizing anticonvulsant best known for controlling seizures with those who suffer from epilepsy. While the medication seemed to initially…
In the third consecutive talcum powder trial, a St. Louis City jury award plaintiff Deborah Giannecchini $2.57 million in compensatory damages and 67.5 million in punitive damages against Johnson & Johnson and the Imerys Talc America defendants for their talc-containing personal hygiene product. Per the…
An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at the Ontario Superior Court of Justice, seeks class-action status, which is expected to be determined within the next six or…
The diabetes drug Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly. In May 2015, the Institute for Safe Medication Practices released…
According to a case management order issued by U.S. District Judge Eldon Fallon, 40 cases will be chosen for the Xarelto bellwether pool, with each side selecting 10 cases and an additional 20 chosen randomly. According to Judge Fallon’s plan: Half of the cases will…
Janssen Pharmaceuticals and its parent company, Johnson & Johnson, recently entered into a settlement agreement with the Commonwealth of Kentucky over allegations surrounding the drug Risperdal. Janssen agreed to: Pay $15.5 million to the state of Kentucky Fully disclose the associated risks of Risperdal to…
The number of lawsuits claiming injuries associated with Xarelto continues to grow in the U.S., and regulators in Canada recently announced a safety review into reports of liver injuries connected with Xarelto use. The August 26 Health Canada safety review cites numerous reports of liver…
A comprehensive medical research bill that passed the U.S. House of Representatives on July 10th includes a provision designed to improve the safety monitoring of medical devices. The amendment, proposed by Rep. Mike Fitzpatrick (R., Pa.), was inspired by a controversial gynecological device – the…
